Applied BioCode Corporation (TPE:6598)

Applied BioCode Statistics

Total Valuation

Applied BioCode has a market cap or net worth of TWD 2.54 billion. The enterprise value is 2.06 billion.

Market Cap	2.54B
Enterprise Value	2.06B

Important Dates

The last earnings date was Monday, May 25, 2026.

Earnings Date	May 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Applied BioCode has 102.82 million shares outstanding. The number of shares has increased by 7.25% in one year.

Current Share Class	102.82M
Shares Outstanding	102.82M
Shares Change (YoY)	+7.25%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	10.34%
Owned by Institutions (%)	6.92%
Float	75.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.45
PB Ratio	3.77
P/TBV Ratio	3.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.24
EV / Sales	3.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.50

Financial Position

The company has a current ratio of 6.02, with a Debt / Equity ratio of 0.08.

Current Ratio	6.02
Quick Ratio	4.72
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-67.69

Financial Efficiency

Return on equity (ROE) is -18.89% and return on invested capital (ROIC) is -12.66%.

Return on Equity (ROE)	-18.89%
Return on Assets (ROA)	-8.94%
Return on Invested Capital (ROIC)	-12.66%
Return on Capital Employed (ROCE)	-17.43%
Weighted Average Cost of Capital (WACC)	7.70%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.50
Inventory Turnover	1.28

Taxes

In the past 12 months, Applied BioCode has paid 53,000 in taxes.

Income Tax	53,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.02% in the last 52 weeks. The beta is 0.64, so Applied BioCode's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+17.02%
50-Day Moving Average	23.29
200-Day Moving Average	22.59
Relative Strength Index (RSI)	63.40
Average Volume (20 Days)	209,037

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Applied BioCode had revenue of TWD 572.33 million and -144.49 million in losses. Loss per share was -1.41.

Revenue	572.33M
Gross Profit	320.36M
Operating Income	-162.52M
Pretax Income	-144.43M
Net Income	-144.49M
EBITDA	-121.39M
EBIT	-162.52M
Loss Per Share	-1.41

Balance Sheet

The company has 542.48 million in cash and 55.83 million in debt, with a net cash position of 486.64 million or 4.73 per share.

Cash & Cash Equivalents	542.48M
Total Debt	55.83M
Net Cash	486.64M
Net Cash Per Share	4.73
Equity (Book Value)	675.50M
Book Value Per Share	6.57
Working Capital	789.92M

Cash Flow

In the last 12 months, operating cash flow was -187.83 million and capital expenditures -8.24 million, giving a free cash flow of -196.07 million.

Operating Cash Flow	-187.83M
Capital Expenditures	-8.24M
Depreciation & Amortization	41.13M
Net Borrowing	-19.17M
Free Cash Flow	-196.07M
FCF Per Share	-1.91

Margins

Gross margin is 55.97%, with operating and profit margins of -28.40% and -25.25%.

Gross Margin	55.97%
Operating Margin	-28.40%
Pretax Margin	-25.24%
Profit Margin	-25.25%
EBITDA Margin	-21.21%
EBIT Margin	-28.40%
FCF Margin	n/a

Dividends & Yields

Applied BioCode does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.25%
Shareholder Yield	-7.25%
Earnings Yield	-5.68%
FCF Yield	-7.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Applied BioCode has an Altman Z-Score of 3.6 and a Piotroski F-Score of 1.

Altman Z-Score	3.6
Piotroski F-Score	1